We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Safety Study Finds Increased Lung Blood Clots, Death In Certain Xeljanz Patients

(February 26, 2019, 11:53 AM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Feb. 25 said a safety clinical trial found an increased risk of pulmonary blood clots and death from Xeljanz when patients...
To view the full article, register now.